The Matsuda et al. series analyzed 50 genes in non‐pretreated primaries and pretreated relapses of 24 IBC and 376 non‐IBC (Matsuda et al., 2017): Two genes (TP53, HER2) were more frequently mutated in IBC. This evidence concerns the gene ERBB2 and inflammatory breast carcinoma.